Barry J. Zeluff, MD
See Publications

Interests

  • Cardiac transplantation

Education

  • Medical School:

    Baylor College Of Medicine

  • Residency:

    Baylor College Of Medicine

  • Fellowships:

    Baylor College Of Medicine

Academic & Clinical Affiliations

  • Baylor St. Luke's Medical Center
  • Kindred Hospital Houston Medical Center

Certifications

  • Infectious Disease, American Board of Internal Medicine
  • Internal Medicine, American Board of Internal Medicine

Honors, Awards and Memberships

Publications

4862227 NC6RFXSH 1 alternatives-to-animal-experimentation 10 date desc Zeluff 2177 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%228R4RAD9C%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Farmakiotis%20and%20Zeluff%22%2C%22parsedDate%22%3A%222016-04-14%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BFarmakiotis%2C%20D.%20and%20%26lt%3Bstrong%26gt%3BZeluff%26lt%3B%5C%2Fstrong%26gt%3B%2C%20B.%20%282016%29.%20Images%20in%20clinical%20medicine.%20Metronidazole-associated%20encephalopathy.%20%26lt%3Bi%26gt%3BN%20Engl%20J%20Med%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B374%26lt%3B%5C%2Fi%26gt%3B%2C%201465.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMicm1505174%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMicm1505174%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Images%20in%20clinical%20medicine.%20Metronidazole-associated%20encephalopathy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dimitrios%22%2C%22lastName%22%3A%22Farmakiotis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barry%22%2C%22lastName%22%3A%22Zeluff%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Apr%2014%2C%202016%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1056%5C%2FNEJMicm1505174%22%2C%22ISSN%22%3A%221533-4406%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22NC6RFXSH%22%5D%2C%22dateModified%22%3A%222019-01-07T17%3A34%3A17Z%22%7D%7D%2C%7B%22key%22%3A%22BY9BV5NF%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Moore%20et%20al.%22%2C%22parsedDate%22%3A%222013%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMoore%2C%20C.%2C%20Addison%2C%20D.%2C%20Wilson%2C%20J.%20M.%20et%20al.%20%282013%29.%20First%20case%20of%20Fusobacterium%20necrophorum%20endocarditis%20to%20have%20presented%20after%20the%202nd%20decade%20of%20life.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B40%26lt%3B%5C%2Fi%26gt%3B%2C%20449%26%23x2013%3B452%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22First%20case%20of%20Fusobacterium%20necrophorum%20endocarditis%20to%20have%20presented%20after%20the%202nd%20decade%20of%20life%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Curtiss%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Addison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20M.%22%2C%22lastName%22%3A%22Wilson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barry%22%2C%22lastName%22%3A%22Zeluff%22%7D%5D%2C%22abstractNote%22%3A%22Fusobacterium%20necrophorum%2C%20an%20obligate%2C%20anaerobic%2C%20filamentous%2C%20gram-negative%20rod%2C%20is%20thought%20to%20be%20a%20normal%20inhabitant%20of%20the%20mucous%20membranes%20in%20human%20beings.%20Fusobacterium%20species%20have%20been%20implicated%20in%20cases%20of%20Lemierre%20syndrome%20and%20other%20pathologic%20conditions.%20Their%20reported%20association%20with%20infective%20endocarditis%20is%20extremely%20rare.%20We%20describe%20the%20case%20of%20a%20previously%20healthy%2034-year-old%20man%20who%20emergently%20presented%20with%20flu-like%20symptoms%20and%20dyspnea%20on%20exertion.%20He%20had%20recently%20undergone%20a%20dental%20procedure.%20Empiric%20antibiotic%20therapy%20was%20initiated.%20Blood%20cultures%20were%20positive%20for%20metronidazole-resistant%20F.%20necrophorum.%20A%20transesophageal%20echocardiogram%20revealed%202%20mobile%20vegetations%20on%20the%20mitral%20valve.%20Despite%20the%20antibiotic%20therapy%2C%20the%20patient%26%23039%3Bs%20respiratory%20status%20worsened%20and%2C%20after%203%20weeks%2C%20he%20died.%20On%20the%20basis%20of%20the%20organism%26%23039%3Bs%20pathophysiology%20and%20the%20patient%26%23039%3Bs%20recent%20dental%20procedure%2C%20the%20oral%20cavity%20was%20the%20likely%20source%20of%20the%20bacteremia.%20Our%20patient%26%23039%3Bs%20case%20underscores%20the%20importance%20of%20recognizing%20Fusobacterium%20bacteremia%20as%20a%20possible%20cause%20of%20endocarditis.%20To%20our%20knowledge%2C%20this%20is%20the%20first%20reported%20case%20of%20monomicrobial%20F.%20necrophorum%20endocarditis%20to%20have%20presented%20in%20a%20patient%20after%20the%202nd%20decade%20of%20life.%20In%20addition%2C%20it%20is%20apparently%20only%20the%204th%20report%20of%20F.%20necrophorum%20mitral%20valve%20endocarditis%20with%20case%20results%20derived%20from%20modern%20culture%20techniques.%22%2C%22date%22%3A%222013%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22NC6RFXSH%22%5D%2C%22dateModified%22%3A%222018-05-02T21%3A04%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22PGUNG5MM%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Aslam%20et%20al.%22%2C%22parsedDate%22%3A%222010-03-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAslam%2C%20S.%2C%20Hernandez%2C%20M.%2C%20Thornby%2C%20J.%20et%20al.%20%282010%29.%20Risk%20factors%20and%20outcomes%20of%20fungal%20ventricular-assist%20device%20infections.%20%26lt%3Bi%26gt%3BClin%20Infect%20Dis%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B50%26lt%3B%5C%2Fi%26gt%3B%2C%20664%26%23x2013%3B671.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1086%5C%2F650454%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1086%5C%2F650454%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Risk%20factors%20and%20outcomes%20of%20fungal%20ventricular-assist%20device%20infections%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saima%22%2C%22lastName%22%3A%22Aslam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Hernandez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Thornby%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barry%22%2C%22lastName%22%3A%22Zeluff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rabih%20O.%22%2C%22lastName%22%3A%22Darouiche%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Infection%20is%20a%20common%20complication%20of%20ventricular-assist%20devices%20%28VADs%29%20and%20is%20associated%20with%20rehospitalization%2C%20thromboembolic%20events%2C%20VAD%20malfunction%2C%20delay%20in%20heart%20transplantation%2C%20and%20a%20high%20mortality%20rate.%20The%20objectives%20of%20this%20study%20were%20to%20investigate%20the%20frequency%20of%20fungal%20VAD%20infections%20and%20assess%20various%20risk%20factors%20and%20their%20effects%20on%20mortality%20as%20compared%20with%20bacterial%20VAD%20infections.%5CnMETHODS%3A%20We%20conducted%20a%20retrospective%20chart%20review%20of%20patients%20with%20infected%20VADs%20at%20a%20single%20tertiary%20care%20center.%20The%20frequency%2C%20risk%20factors%2C%20and%20outcomes%20of%20fungal%20versus%20bacterial%20VAD%20infections%20were%20compared.%5CnRESULTS%3A%20Of%20the%20300%20patients%20who%20received%20a%20VAD%2C%20108%20%2836%25%29%20developed%20VAD%20infection%2C%20including%2085%20bacterial%20and%2023%20fungal%20infections.%20Most%20common%20bacterial%20causes%20of%20infection%20were%20Staphylococcus%20aureus%2C%20coagulase-negative%20staphylococci%2C%20enterococci%2C%20and%20Pseudomonas%20aeuruginosa.%20The%20most%20common%20fungal%20etiologic%20agent%20was%20Candida%20albicans.%20Only%20the%20use%20of%20total%20parenteral%20nutrition%20was%20associated%20with%20the%20development%20of%20a%20fungal%20VAD%20infection%20in%20multivariate%20analysis%20%28odds%20ratio%2C%206.95%3B%2095%25%20confidence%20interval%2C%201.71-28.16%3B%20P%3D.007%29.%20Patients%20who%20experienced%20fungal%20VAD%20infection%20were%20less%20likely%20to%20be%20cured%20%2817.4%25%20vs%2056.3%25%3B%20P%3D.001%29%20and%20had%20greater%20mortality%20%2891%25%20vs%2061%25%3B%20P%3D.006%29%2C%20compared%20with%20those%20who%20experienced%20bacterial%20VAD%20infection.%5CnCONCLUSIONS%3A%20Fungi%20were%20responsible%20for%20approximately%20one-fifth%20of%20VAD%20infections%20and%20were%20associated%20with%20a%20mortality%20rate%20of%2091%25.%20Restriction%20of%20total%20parenteral%20nutrition%20use%20is%20essential%20in%20decreasing%20the%20rate%20of%20fungal%20VAD%20infection.%20Trials%20are%20needed%20for%20investigating%20the%20use%20of%20echinocandins%20or%20lipid%20formulations%20of%20amphotericin%20B%20for%20prevention%20and%5C%2For%20treatment%20of%20fungal%20VAD%20infection.%22%2C%22date%22%3A%22Mar%2001%2C%202010%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1086%5C%2F650454%22%2C%22ISSN%22%3A%221537-6591%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22NC6RFXSH%22%5D%2C%22dateModified%22%3A%222018-05-02T19%3A16%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22SPQ7BQ9P%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hernandez%20et%20al.%22%2C%22parsedDate%22%3A%222009-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHernandez%2C%20M.%20D.%2C%20Mansouri%2C%20M.%20D.%2C%20Aslam%2C%20S.%20et%20al.%20%282009%29.%20Efficacy%20of%20combination%20of%20N-acetylcysteine%2C%20gentamicin%2C%20and%20amphotericin%20B%20for%20prevention%20of%20microbial%20colonization%20of%20ventricular%20assist%20devices.%20%26lt%3Bi%26gt%3BInfect%20Control%20Hosp%20Epidemiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B30%26lt%3B%5C%2Fi%26gt%3B%2C%20190%26%23x2013%3B192.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1086%5C%2F593205%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1086%5C%2F593205%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Efficacy%20of%20combination%20of%20N-acetylcysteine%2C%20gentamicin%2C%20and%20amphotericin%20B%20for%20prevention%20of%20microbial%20colonization%20of%20ventricular%20assist%20devices%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20D.%22%2C%22lastName%22%3A%22Hernandez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammad%20D.%22%2C%22lastName%22%3A%22Mansouri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saima%22%2C%22lastName%22%3A%22Aslam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barry%22%2C%22lastName%22%3A%22Zeluff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rabih%20O.%22%2C%22lastName%22%3A%22Darouiche%22%7D%5D%2C%22abstractNote%22%3A%22We%20assessed%20the%20in%20vitro%20antimicrobial%20activity%20and%20the%20in%20vivo%20efficacy%20of%20dipping%20ventricular%20assist%20devices%20in%20a%20combination%20of%20N-acetylcysteine%2C%20gentamicin%2C%20and%20amphotericin%20B%20%28NAC%5C%2FG%5C%2FA%29.%20Ventricular%20assist%20devices%20dipped%20in%20NAC%5C%2FG%5C%2FA%20exhibited%20broad-spectrum%20antimicrobial%20activity%20in%20vitro%20and%20were%20less%20likely%20than%20undipped%20devices%20to%20become%20colonized%20with%20Staphylococcus%20aureus%20in%20a%20rabbit%20model.%22%2C%22date%22%3A%22Feb%202009%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1086%5C%2F593205%22%2C%22ISSN%22%3A%221559-6834%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22NC6RFXSH%22%5D%2C%22dateModified%22%3A%222018-05-02T19%3A16%3A06Z%22%7D%7D%5D%7D
Farmakiotis, D. and Zeluff, B. (2016). Images in clinical medicine. Metronidazole-associated encephalopathy. N Engl J Med 374, 1465. https://doi.org/10.1056/NEJMicm1505174.
Moore, C., Addison, D., Wilson, J. M. et al. (2013). First case of Fusobacterium necrophorum endocarditis to have presented after the 2nd decade of life. Tex Heart Inst J 40, 449–452
Aslam, S., Hernandez, M., Thornby, J. et al. (2010). Risk factors and outcomes of fungal ventricular-assist device infections. Clin Infect Dis 50, 664–671. https://doi.org/10.1086/650454.
Hernandez, M. D., Mansouri, M. D., Aslam, S. et al. (2009). Efficacy of combination of N-acetylcysteine, gentamicin, and amphotericin B for prevention of microbial colonization of ventricular assist devices. Infect Control Hosp Epidemiol 30, 190–192. https://doi.org/10.1086/593205.